U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C5H4N4O
Molecular Weight 136.1115
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of HYPOXANTHINE

SMILES

O=C1NC=NC2=C1N=CN2

InChI

InChIKey=FDGQSTZJBFJUBT-UHFFFAOYSA-N
InChI=1S/C5H4N4O/c10-5-3-4(7-1-6-3)8-2-9-5/h1-2H,(H2,6,7,8,9,10)

HIDE SMILES / InChI

Molecular Formula C5H4N4O
Molecular Weight 136.1115
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description
Curator's Comment: The description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/26196868 | https://www.ncbi.nlm.nih.gov/pubmed/17149876 | https://www.ncbi.nlm.nih.gov/pubmed/25956679 | https://www.ncbi.nlm.nih.gov/pubmed/28238512 | https://www.ncbi.nlm.nih.gov/pubmed/3670521

Hypoxanthine is a naturally occurring purine derivative and a reaction intermediate in the metabolism of adenosine and in the formation of nucleic acids by the salvage pathway. Hypoxanthine is a necessary additive in the certain cell, bacteria, and parasite cultures as a substrate and nitrogen source. For example, it is commonly a required reagent in malaria parasite cultures, since Plasmodium falciparum requires a source of hypoxanthine for nucleic acid synthesis and energy metabolism.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Diagnostic
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Is skeletal muscle damaged by the oxidative stress following anaerobic exercise?
2001
The mechanism of switching among multiple BER pathways.
2001
Base excision repair in nuclear and mitochondrial DNA.
2001
Identification of a new point mutation in the human xanthine dehydrogenase gene responsible for a case of classical type I xanthinuria.
2001 Apr
DNA triple-helix formation at pyrimidine-purine inversion sites.
2001 Apr-Jul
Unaltered apoptotic behaviour of mononuclear cells from patients with sporadic Creutzfeldt-Jakob disease.
2001 Aug
Isolation and characterization of the Xanthine dehydrogenase gene of the Mediterranean fruit fly, Ceratitis capitata.
2001 Aug
Pyruvate improves cerebral metabolism during hemorrhagic shock.
2001 Aug
Structure-activity relationships and inhibitory effects of various purine derivatives on the in vitro growth of Plasmodium falciparum.
2001 Aug 1
L-tyrosine and nitric oxide synergize to prevent cytotoxic effects of superoxide.
2001 Aug 28
Reaction of superoxide and nitric oxide with peroxynitrite. Implications for peroxynitrite-mediated oxidation reactions in vivo.
2001 Aug 3
Sudden infant death syndrome (SIDS): T-cell immunodeficiency--Part 1.
2001 Feb
Protection of the rat liver against rewarming ischemic injury by University of Wisconsin solution.
2001 Feb
Study of the interaction of cis-dichloro-(1,2 diethyl-3-aminopyrrolidine)Pt(II) complex with poly(I), poly(C) and poly(I) x poly(C).
2001 Jul
Random amplified ribosomal DNA restriction analysis for rapid identification of thermophilic Actinomycete-like bacteria involved in hypersensitivity pneumonitis.
2001 Jul
The effect of allopurinol on focal cerebral ischaemia: an experimental study in rabbits.
2001 Jul
Separation of inosine, hypoxanthine, and guanosine by high-performance liquid chromatography on silica.
2001 Jul
In vitro and in vivo properties of novel nucleoside transport inhibitors with improved pharmacological properties that potentiate antifolate activity.
2001 Jul
Middle cerebral artery occlusion and reperfusion in primates monitored by microdialysis and sequential positron emission tomography.
2001 Jul
Nitric oxide- and nitric oxide donors-induced relaxation and its modulation by oxidative stress in piglet pulmonary arteries.
2001 Jul
Sudden infant death syndrome Part 2: the response of the reticuloendothelial system to hypoxemia and infection.
2001 Jul
Purine salvage to adenine nucleotides in different skeletal muscle fiber types.
2001 Jul
Investigation of the functional role of active site loop II in a hypoxanthine phosphoribosyltransferase.
2001 Jul 27
Antiplasmodial and antioxidant isofuranonaphthoquinones from the roots of Bulbine capitata.
2001 Jun
Altered purine nucleotide degradation during exercise in patients with essential hypertension.
2001 Jun
Changes in serum hypoxanthine levels by exercise in obese subjects.
2001 Jun
[Biochemical parameters predictive of neuronal damage in childhood].
2001 Jun 16-30
Resveratrol suppresses hepatoma cell invasion independently of its anti-proliferative action.
2001 Jun 26
Superoxide potently induces ceramide formation in glomerular endothelial cells.
2001 Jun 8
[Two cases of exercise-induced acute renal failure with idiopathic renal hypouricemia].
2001 May
Adenine deaminase activity of the yicP gene product of Escherichia coli.
2001 May
Oxidative stress impairs insulin internalization in endothelial cells in vitro.
2001 May
Hepatic xanthine levels as viability predictor of livers procured from non-heart-beating donor pigs.
2001 May 15
[Post-radiation changes in kinetic parameters of purine-catabolizing enzymes in rat blood serum after combined action of external and internal irradiation caused by 137Cs].
2001 May-Jun
[Polymethylene derivatives of nucleic bases with omega-functional groups. II. Adenine and hypoxanthine derivatives].
2001 May-Jun
Off-pump versus on-pump coronary artery bypass grafting: oxidative stress and renal function.
2001 Nov
Inhibitory effects of methylxanthines on the pre-eclamptic-like symptoms in ewes.
2001 Nov
Folate deficiency-induced oxidative stress and apoptosis are mediated via homocysteine-dependent overproduction of hydrogen peroxide and enhanced activation of NF-kappaB in human Hep G2 cells.
2001 Oct
Addition of hypoxanthine to culture media allows in vitro cultivation of Babesia bovis and B. bigemina at reduced serum concentrations.
2001 Oct
Effect of fenofibrate on plasma concentration and urinary excretion of purine bases and oxypurinol.
2001 Oct
Effects of storage temperature and preservative treatment on shelf life of the pond-raised freshwater fish, silver perch (Bidyanus bidyanus).
2001 Oct
Effect of norepinephrine on the urinary excretion of purine bases and oxypurinol.
2001 Oct
Sperm disposal system in spermatic granuloma: a link with superoxide radicals.
2001 Oct
Catabolism of exogenous deoxyinosine in cultured epithelial amniotic cells.
2001 Oct 3
Concentrations of nucleotides, nucleosides, purine bases, oxypurines, uric acid, and neuron-specific enolase in the cerebrospinal fluid of children with sepsis.
2001 Sep
Early onset of lipid peroxidation after human traumatic brain injury: a fatal limitation for the free radical scavenger pharmacological therapy?
2001 Sep
Newborn piglets with meconium aspiration resuscitated with room air or 100% oxygen.
2001 Sep
Protein kinase C, rather than protein kinase A is involved in follicle-stimulating hormone-mediated meiotic resumption of mouse cumulus cell-enclosed oocytes in hypoxanthine-supplemented medium.
2001 Sep
Molecular analysis of HPRT1(+) somatic cell hybrids derived from a carrier of an HPRT1 mutation responsible for Lesch-Nyhan syndrome.
2001 Sep 15
Synthesis and purine receptor affinity of 6-oxopurine nucleosides and nucleotides containing (N)-methanocarba-pseudoribose rings.
2001 Sep 3
Patents

Patents

Sample Use Guides

2 μL of a solution of hypoxanthine (20 pmol/2 μL) or vehicle (saline 0.9 %) was administered in the right striatum of the rats 1 μL per minute.
Route of Administration: Other
The in vitro drug sensitivity of the Cambodian isolates was assessed by use of a classical isotopic 48- h test. fresh blood samples were washed three times with RPMI 1640 medium (GibcoTM, Invitrogen Corporation, France) by centrifugation (800×g, 10 min). The parasites were then tested directly without culture adaptation. The infected erythrocytes (1.5% hematocrit, 0.1–1% parasitemia) were suspended in complete RPMI medium supplemented with 10% of decomplemented human AB+ serum (Biomedia, France) and buffered with 25 mM/l Hepes and 25 mM/l NaHCO3. The mixture was distributed (200 mkl per well) into the 96-well test plates that had been pre-coated with antimalarial agents. Each plate included two drug-free control wells and one control well without parasites. The culture plates were incubated for 48 h at 37 ◦Cina5%CO2 atmosphere. [3H]Hypoxanthine (0.5 mkCi/well; Amersham Biosciences, France) was used to assess parasite growth. Each isolate was tested once in duplicate in the microplates with serial dilutions of drugs. Drug response was quantified by monitoring [3H]hypoxanthine uptake in aWallac MicroBeta Trilux counter (Perkin-Elmer, France). At the end of the incubation period, the plates were frozen at −20 ◦C and thawed to lyse the cells. After collection on glassfiber filter paper using a cell harvester, the amount of [3H]hypoxanthine incorporated into the parasites nucleoprotein was determined.
Substance Class Chemical
Created
by admin
on Fri Dec 15 15:09:52 UTC 2023
Edited
by admin
on Fri Dec 15 15:09:52 UTC 2023
Record UNII
2TN51YD919
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
HYPOXANTHINE
MI   WHO-DD  
Systematic Name English
NSC-14665
Code English
AZATHIOPRINE IMPURITY F [EP IMPURITY]
Common Name English
MERCAPTOPURINE IMPURITY, HYPOXANTHINE- [USP IMPURITY]
Common Name English
SARCINE
Common Name English
PURIN-6(1H)-ONE
Systematic Name English
1,7-DIHYDRO-6H-PURIN-6-ONE
Systematic Name English
SARKIN
Common Name English
HYPOXANTHINE [MI]
Common Name English
DIDANOSINE RELATED COMPOUND A
USP   USP-RS  
Common Name English
DIDANOSINE IMPURITY A [EP IMPURITY]
Common Name English
MERCAPTOPURINE IMPURITY, HYPOXANTHINE- [EP IMPURITY]
Common Name English
DIDANOSINE RELATED COMPOUND A [USP IMPURITY]
Common Name English
DIDANOSINE IMPURITY A
EP  
Common Name English
DIDANOSINE RELATED COMPOUND A [USP-RS]
Common Name English
Hypoxanthine [WHO-DD]
Common Name English
Classification Tree Code System Code
LOINC 2452-1
Created by admin on Fri Dec 15 15:09:52 UTC 2023 , Edited by admin on Fri Dec 15 15:09:52 UTC 2023
LOINC 75135-4
Created by admin on Fri Dec 15 15:09:52 UTC 2023 , Edited by admin on Fri Dec 15 15:09:52 UTC 2023
LOINC 75123-0
Created by admin on Fri Dec 15 15:09:52 UTC 2023 , Edited by admin on Fri Dec 15 15:09:52 UTC 2023
LOINC 2453-9
Created by admin on Fri Dec 15 15:09:52 UTC 2023 , Edited by admin on Fri Dec 15 15:09:52 UTC 2023
LOINC 17004-3
Created by admin on Fri Dec 15 15:09:52 UTC 2023 , Edited by admin on Fri Dec 15 15:09:52 UTC 2023
NCI_THESAURUS C62554
Created by admin on Fri Dec 15 15:09:52 UTC 2023 , Edited by admin on Fri Dec 15 15:09:52 UTC 2023
LOINC 38366-1
Created by admin on Fri Dec 15 15:09:52 UTC 2023 , Edited by admin on Fri Dec 15 15:09:52 UTC 2023
NCI_THESAURUS C786
Created by admin on Fri Dec 15 15:09:52 UTC 2023 , Edited by admin on Fri Dec 15 15:09:52 UTC 2023
Code System Code Type Description
MERCK INDEX
m6178
Created by admin on Fri Dec 15 15:09:52 UTC 2023 , Edited by admin on Fri Dec 15 15:09:52 UTC 2023
PRIMARY Merck Index
EPA CompTox
DTXSID8045983
Created by admin on Fri Dec 15 15:09:52 UTC 2023 , Edited by admin on Fri Dec 15 15:09:52 UTC 2023
PRIMARY
FDA UNII
2TN51YD919
Created by admin on Fri Dec 15 15:09:52 UTC 2023 , Edited by admin on Fri Dec 15 15:09:52 UTC 2023
PRIMARY
ECHA (EC/EINECS)
200-697-3
Created by admin on Fri Dec 15 15:09:52 UTC 2023 , Edited by admin on Fri Dec 15 15:09:52 UTC 2023
PRIMARY
CAS
68-94-0
Created by admin on Fri Dec 15 15:09:52 UTC 2023 , Edited by admin on Fri Dec 15 15:09:52 UTC 2023
PRIMARY
RS_ITEM_NUM
1191226
Created by admin on Fri Dec 15 15:09:52 UTC 2023 , Edited by admin on Fri Dec 15 15:09:52 UTC 2023
PRIMARY
CHEBI
17368
Created by admin on Fri Dec 15 15:09:52 UTC 2023 , Edited by admin on Fri Dec 15 15:09:52 UTC 2023
PRIMARY
WIKIPEDIA
HYPOXANTHINE
Created by admin on Fri Dec 15 15:09:52 UTC 2023 , Edited by admin on Fri Dec 15 15:09:52 UTC 2023
PRIMARY
NCI_THESAURUS
C29105
Created by admin on Fri Dec 15 15:09:52 UTC 2023 , Edited by admin on Fri Dec 15 15:09:52 UTC 2023
PRIMARY
DRUG BANK
DB04076
Created by admin on Fri Dec 15 15:09:52 UTC 2023 , Edited by admin on Fri Dec 15 15:09:52 UTC 2023
PRIMARY
SMS_ID
100000077634
Created by admin on Fri Dec 15 15:09:52 UTC 2023 , Edited by admin on Fri Dec 15 15:09:52 UTC 2023
PRIMARY
PUBCHEM
790
Created by admin on Fri Dec 15 15:09:52 UTC 2023 , Edited by admin on Fri Dec 15 15:09:52 UTC 2023
PRIMARY
MESH
D019271
Created by admin on Fri Dec 15 15:09:52 UTC 2023 , Edited by admin on Fri Dec 15 15:09:52 UTC 2023
PRIMARY
EVMPD
SUB14172MIG
Created by admin on Fri Dec 15 15:09:52 UTC 2023 , Edited by admin on Fri Dec 15 15:09:52 UTC 2023
PRIMARY
NSC
14665
Created by admin on Fri Dec 15 15:09:52 UTC 2023 , Edited by admin on Fri Dec 15 15:09:52 UTC 2023
PRIMARY
Related Record Type Details
METABOLITE -> PARENT
Related Record Type Details
PARENT -> IMPURITY
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
PARENT -> IMPURITY
PARENT -> IMPURITY
In the chromatogram obtained with solution (3) the area of any peak corresponding to impurity A (hypoxanthine) is not greater than the area of the principal peak obtained with solution (1) (0.5%).